0001209191-21-040427.txt : 20210614 0001209191-21-040427.hdr.sgml : 20210614 20210614200052 ACCESSION NUMBER: 0001209191-21-040427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210611 FILED AS OF DATE: 20210614 DATE AS OF CHANGE: 20210614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karydas Daphne CENTRAL INDEX KEY: 0001816952 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 211016317 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE STREET 2: BUILDING D, FLOOR 3 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-11 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001816952 Karydas Daphne C/O LOGICBIO THERAPEUTICS, INC. 65 HAYDEN AVE, FLOOR 2 LEXINGTON MA 02421 1 0 0 0 Stock Option (right to buy) 4.59 2021-06-11 4 A 0 12500 0.00 A 2031-06-11 Common Stock 12500 12500 D The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan as provided under the Company's compensation policy for non-employee directors. All of the options will vest and become exercisable on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer through the vesting date. /s/ Jonathan Quick, as Attorney-in-Fact 2021-06-14 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT

POWER OF ATTORNEY

	Know all by these present, that the undersigned hereby constitutes and appoints
each of Frederic Chereau, Cecilia Jones, Andrea Paul and Jonathan Quick signing
singly, as the undersigned's true and lawful attorney-in-fact to:

(1)	prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents necessary or appropriate
to obtain codes and passwords enabling the undersigned to make electronic
filings with the SEC of reports required by Section 16(a) of the Securities
Exchange Act of 1934, as amended (the "Act") or any rule or regulation of the
SEC;

(2)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director and/or shareholder of LogicBio Therapeutics, Inc. (the
"Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Act, and
the rules thereunder, and/or Forms 144 in accordance with Rule 144 under the
Securities Act of 1933, as amended ("Rule 144");

(3)	do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute any such Form 3, 4 or 5 or
Form 144, and timely file such form with the SEC and any stock exchange or
similar authority; and

(4)	take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-facts discretion.

The undersigned hereby grants to each attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all the acts such attorney-in-fact shall lawfully do or
cause to be done by virtue of this Power of Attorney and the rights and powers
herein granted.

The undersigned acknowledges that neither the Company nor any attorney-in-fact,
in serving in such capacity at the request of the undersigned, is assuming any
obligation or liability of the undersigned under Section 16 of the Act or Rule
144, including any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Act.

This Power of Attorney revokes all powers of attorney previously executed by the
undersigned with respect to the subject matter of this Power of Attorney. This
Power of Attorney shall remain in full force and effect until the undersigned is
no longer required to file Forms 3, 4 and 5, or Forms 144, with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to each
of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of June 10, 2021.

/s/ Daphne Karydas
Daphne Karydas